For laboratory and educational research use only. Not medical advice.
Women's Peptide Research
Ask Vera
Home  /  Peptide Database

Peptide database

Browse and explore comprehensive, sex-disaggregated peptide profiles.

91 peptides indexed · 82 reviewedASK VERA
16 results in this view
A
Arginine Vasopressin
AVP
hormoneantidiureticapproved

Arginine vasopressin is the body's antidiuretic hormone; its synthetic form (vasopressin injection) is FDA-approved for vasodilatory shock and diabetes…

Typical dose
Weight-based intravenous infusions per approved labels (shock, diabetes insipidus); not a self-administered research dose.
Route
intravenous
A4,072 of 12,241 female-tagged
12241 studies ↗
B
Bromantane
Ladasten
actoprotectorstimulant-adaptogenapproved-ex-us

Bromantane is an 'actoprotector' developed in Russia and approved there (as Ladasten) for asthenic conditions, combining mild stimulant and anxiolytic effects.

Typical dose
Oral doses (e.g., ~50–100 mg/day) are described in the Russian literature; not approved outside those markets.
Route
oral
C16 of 62 female-tagged
62 studies ↗
C
Cerebrolysin
FPF-1070
neuropeptide-preparationneuroprotectiveapproved-ex-us

Cerebrolysin is a porcine-brain-derived peptide preparation used clinically in many countries for stroke, traumatic brain injury, and dementia.

Typical dose
Intravenous courses (e.g., ~10–30 mL/day) are used in the countries where it is marketed; investigational in the US.
Route
intravenous
B172 of 629 female-tagged
629 studies ↗
D
Davunetide
NAP
neuroprotectivemicrotubulefailed-phase3

Davunetide (NAP) is a neuroprotective peptide studied for tauopathies; a large Phase 2/3 trial in progressive supranuclear palsy failed to meet its endpoints.

Typical dose
Intranasal dosing was used in the Phase 2/3 program; investigational, no approved dose.
Route
intranasal
B24 of 102 female-tagged
102 studies ↗
D
Dihexa
PNB-0408
angiotensin-iv-analoghgf-cmetpreclinical

Dihexa is an angiotensin IV-derived peptide studied preclinically for synapse formation and cognition via the HGF/c-Met system.

Typical dose
No established human dose; cognitive effects shown in animal models.
Route
oral
D0 of 17 female-tagged
17 studies ↗
G
GPE
Glycine-Proline-Glutamate
neuroprotectiveigf-1-derivedpreclinical

GPE (glycine-proline-glutamate) is an IGF-1-derived neuroprotective tripeptide studied preclinically for brain injury and neurodegeneration.

Typical dose
No established human dose for GPE; neuroprotective effects shown in preclinical models.
Route
intravenous
D11 of 97 female-tagged
97 studies ↗
N
Neuropeptide S
NPS
neuropeptidearousal-anxietypreclinical

Neuropeptide S is an endogenous neuropeptide studied for arousal, anxiety, and memory, mainly in animal models.

Typical dose
No established human dose; effects shown in animal models.
Route
intranasal
D80 of 420 female-tagged
420 studies ↗
N
Noopept
GVS-111
nootropicdipeptideneuroprotective

Noopept (omberacetam) is a synthetic dipeptide nootropic developed in Russia and used there clinically for cognitive and asthenic complaints.

Typical dose
Oral doses around 10–20 mg/day are described in the Russian literature; not approved outside those markets.
Route
oral
C9 of 107 female-tagged
107 studies ↗
O
Orexin-A
Hypocretin-1
neuropeptidewakefulnessnarcolepsy

Orexin-A (hypocretin-1) is a wake-promoting neuropeptide whose deficiency causes narcolepsy.

Typical dose
Intranasal orexin-A has been used in small human studies; no established therapeutic dose.
Route
intranasal
C587 of 2,369 female-tagged
2369 studies ↗
P
P21 (P021)
P021
neurotrophicciliary-neurotrophic-factorpreclinical

P21 (P021) is a small neurotrophic peptide mimetic derived from ciliary neurotrophic factor, studied preclinically for neurogenesis and Alzheimer's-related…

Typical dose
No established human dose; effects shown in animal models.
Route
subcutaneous
D7 of 17 female-tagged
17 studies ↗
P
PE-22-28
Spadin analog
trek-1-blockerantidepressantpreclinical

PE-22-28 is a synthetic analog of spadin that blocks the TREK-1 potassium channel, studied preclinically for rapid antidepressant-like effects.

Typical dose
No established human dose; antidepressant-like effects shown in animal models.
Route
subcutaneous
D5 of 40 female-tagged
40 studies ↗
P
Pinealon
EDR
short-peptidebioregulatorneuroprotective

Pinealon is a short synthetic tripeptide (Glu-Asp-Arg / EDR) among the Khavinson 'short peptide bioregulators,' studied for neuroprotective effects.

Typical dose
No established human dose; studied in cell and animal models.
Route
oral
D3 of 18 female-tagged
18 studies ↗
P
PRL-8-53
Methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate
nootropicsingle-studyunreplicated

PRL-8-53 is a synthetic compound known almost entirely from a single 1978 human study reporting improved word retention.

Typical dose
Low oral doses were used in the single 1978 study; no established or validated dose.
Route
oral
E0 of 1 female-tagged
1 studies ↗
S
Selank
TP-7
neuropeptideanxiolytic-research

Selank is a synthetic tuftsin-analog heptapeptide studied in neuropeptide and behavioral research.

Typical dose
Reported in early studies; no established therapeutic dose in most jurisdictions.
Route
intranasal
C26 of 125 female-tagged
125 studies ↗
S
Semax
ACTH(4-10) analog
neuropeptidebdnfnootropic

Semax is an ACTH(4-10)-derived peptide studied in neuroscience research for effects on neurotrophic signaling.

Typical dose
Reported in early studies; no established therapeutic dose in most jurisdictions.
Route
intranasal
C33 of 206 female-tagged
206 studies ↗
V
VIP (10-28)
VIP(10-28)
vip-fragmentresearch-probepreclinical

VIP(10-28) is a fragment of vasoactive intestinal peptide used mainly as a mechanistic probe and VIP antagonist in research, including small human…

Typical dose
No established human dose; used as a mechanistic probe/antagonist in research.
Route
intravenous
D13 of 79 female-tagged
79 studies ↗

About the peptide database

How many peptides are in the database?

The database indexes 91 research peptides, of which 82 have completed a full sex-disaggregated evidence review. The rest carry their research facts while the female-evidence review is written.

How is each peptide's evidence grade decided?

Every compound's A–E grade is derived from published study fields by a fixed, transparent rubric, not an opaque score. Grade A requires human evidence that included female subjects; grade E means anecdotal, in-vitro, or no indexed studies.

What does the female study count tell me?

It shows how many indexed studies included female subjects and, separately, how many reported outcomes by sex. Where no qualifying female study exists, the profile says "unstudied" rather than extrapolating from male data.

Can I search the database by symptom or goal?

Yes. Use the search box to match compound names, aliases, and research tags, or filter by research area such as hormonal, metabolic, skin, or recovery. Vera, the cited AI assistant, can also answer questions across the whole database.